Connect with us

Health

Nigeria Monitors New Strains of COVID-19, Other Diseases

Published

on

new strains of COVID-19

By Adedapo Adesanya

The Nigeria Centre for Disease Control (NCDC) has said it is on high alert amid global concerns over new strains of COVID-19.

This was made known yesterday at a press conference in Abuja, where the health body said over 663 million confirmed cases and over 6.7 million deaths had been reported globally.

Speaking at the event, NCDC Director General, Dr Ifedayo Adetifa, said: “Globally, more than three million new cases and ten thousand deaths have been reported in the week of December 26, 2022, to January 1, 2023. This represents a reduction in weekly cases and deaths of 22 per cent and 12 per cent, respectively.

“The African Region reports a 73 per cent and 32 per cent decrease in new cases and deaths compared to the previous week.

“In the Americas and Western Pacific (including China), there has been a 74 per cent and 29 per cent increase in cases and a 49 per cent and 35 per cent increase in deaths, respectively. The increase in these countries, in part, is a component of the winter exacerbation of respiratory illness,” the DG said.

Dr Adetifa said the resurgence of COVID-19 in China, following the relaxation of the country’s zero-COVID policy and the unsurprising increase in cases, hospitalisation and deaths, also attracts concerns about the possible emergence of new variants.

He said the variants circulating in China are predominantly BA.5.2 and Bf.7. According to him, these variants have been circulating in other parts of the world, including Nigeria, since 2022.

The Omicron sub-variant, XBB.1.5, which was originally detected in New York in October 2022, is also on the increase in the US and Europe and has now been identified in more than 25 countries. The XBB.1.5 is the most transmissible form of Omicron, but it is not clear if it is more virulent than its ancestor.

The epidemiologist noted that in Nigeria, NCDC has 5,708,974 samples tested, 266,463 confirmed cases, 259,850 discharged cases and, unfortunately 3,155 deaths recorded in 36 states and the Federal Capital Territory (FCT).

He said COVID-19 has and continues to follow a different epidemiological course in Nigeria and most of Africa, with lesser cases, admissions, and deaths from the Omicron sub-lineages.

On efforts to contain the current threat, he said: “The NCDC-led COVID-19 Emergency Operation Centre (EOC) is closely monitoring the rise in the new Omicron sub-lineage, XBB.1.5, in the U.K. and U.S., and the current resurgence in China and other countries with a high volume of traffic to and from Nigeria.

“The sub-lineages partly responsible for the current increase in COVID-19 cases in other countries (XBB. 1.5 and BF.7) have not yet been detected in the country as of November 2022. We are working on completing testing and analysis for December 2022.

“Since the detection of the Omicron variant in December 2021, its sub-lineage (BQ.1/BQ.1.1) has been dominant in Nigeria.

“It is important to note that regardless of COVID-19 variants in different parts of the world, severe disease, admissions, and deaths disproportionately affect the unvaccinated and those with established risk factors, such as older people and people with co-morbidities.

“The most important action for Nigerians to take is to get vaccinated against COVID-19, as the vaccine is the most important intervention for preventing severe disease, hospitalisation, and death.

“Additionally, though COVID-19 protocols and restrictions have been eased, people at high risk for severe COVID-19 are advised to continue to adhere to recommended non-pharmaceutical intervention (NPIs), such as the use of face masks, good hand and respiratory hygiene and avoidance of crowded spaces.”

On other infectious diseases, he said: “We continue to respond to infectious diseases, including Lassa fever, Mpox, and more. To date, there are 8,202 suspected cases and 1,067 confirmed cases of Lassa fever across 27 states and 112 council areas.

“Cumulatively, from Week 1 to Week 52, 2022, 189 deaths have been reported with a case fatality rate (FR) of 17.7 per cent, which is lower than the CFR for the same period in 2021 (20.0 per cent). 72 per cent of all confirmed Lassa fever cases in 2022 were reported from three states (Ondo, Edo and Bauchi).

“Most recently, the NCDC, in collaboration with partners, federal and state stakeholders of the Technical Working Group (TWG), successfully conducted finalisation and validation of a five-year strategic plan to reduce Lassa fever fatality ratio in the country to less than ten per cent.

“We continually appeal to Nigerians to practice personal and environmental hygiene to prevent the infestation of rats in our homes and communities, especially during this dry season, which is when we typically record more cases of Lassa fever cases.”

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Click to comment

Leave a Reply

Health

Mums Feel Warmth Initiative Raises Postpartum Depression Awareness

Published

on

Mums Feel Warmth Postpartum Depression

By Modupe Gbadeyanka

A transformative webinar to raise awareness on postpartum depression (PPD) by nursing mothers has been organised by MSc Media and Communication students from the School of Media and Communications of the Pan-Atlantic University.

The programme titled Beyond Baby Blues: Understanding and Overcoming Postpartum Depression was held on January 7, 2025.

It was put together by the students under the Mums Feel Warmth initiative, with experts in the field invited to speak on the matter aimed at empowering mothers and fostering a sense of reassurance.

The webinar was to highlight the journey through postpartum depression, offering a message of hope, resilience, and the importance of mental health support for mothers everywhere.

One of the speakers, Dr Laja Odunuga, who is the Care Coordinator for AVON HMO, explained the difference between the common “baby blues” and the more severe, long-lasting PPD.

The discussion highlighted how PPD can manifest not just as sadness but through severe fatigue, disconnection from the newborn, and loss of interest in activities, which can last well beyond the typical two-week period associated with baby blues.

Another expert, Ms Otomfon Ibanga, the Assistant Lead Nurse for Q-Life Family Clinic, emphasised the role of support systems, urging families and friends to be vigilant for signs of PPD and to provide a nurturing environment.

She also discussed prevention strategies, including prenatal planning for support structures and post-delivery management through therapy or medication.

On his part, Dr Chimaraoke Obialo, who is the Medical Director of Life Amada Health Consultancy, addressed the stigma surrounding PPD, advocating for education to transform societal perceptions from judgement to support.

The webinar underscored the need for community involvement, not just in recognising symptoms but in actively participating in the healing process by offering emotional and practical support.

The Mums Feel Warmth webinar was more than just an educational session; it was a call to action for society to embrace and support new mothers dealing with PPD.

By fostering open conversations and providing platforms for sharing experiences, Mums Feel Warmth continues to lead the charge against the stigma of PPD.

The commitment shown by the panellists and attendees alike promises a future where every mother has access to the understanding and care needed to navigate through the complexities of postpartum depression, ensuring that the joy of motherhood is not overshadowed by mental health challenges.

Mums Feel Warmth, with its core values of empathy, compassion, hope, community, and education, speaks to the Sustainable Development Goal 3, advocating for good health and well-being.

The initiative is breaking the silence around PPD, a condition that can significantly impact new mothers in the critical period following childbirth.

Continue Reading

Health

NCDC Monitors HMPV Situation, Affirms Nigeria at Moderate Risk

Published

on

HMPV

By Adedapo Adesanya

The Nigeria Centre for Disease Control (NCDC) says the country is at “moderate” risk for Human Metapneumovirus (HMPV), a virus that leads to an upper respiratory tract infection with symptoms like cough, fever, and nasal congestion.

In a public health advisory, the Nigerian health agency said the federal government is closely monitoring the outbreak of the virus and is taking safety measures to “strengthen the country’s preparedness and response capacity”.

Recent reports indicate a significant rise in HMPV cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France, and Germany, particularly during the winter season.

The NCDC said it conducted a risk assessment for the HMPV in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the US Centres for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA).

“The assessment classified the risk of HMPV for Nigeria as moderate. This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts,” the advisory said.

It said the NCDC is working to give Nigerians “timely, accurate information and guidance to keep the Nigerian public informed and prepared”.

NCDC noted that it “in collaboration with Port Health Authorities, is taking proactive steps to ensure robust preparedness at all international points of entry (PoEs) in response to the dynamic risk assessment for Human Metapneumovirus (HMPV).

“These measures are designed to mitigate the potential risk of HMPV transmission through international travel.”

HMPV was first identified in the Netherlands in 2001 and the virus spreads through direct contact between people or when someone touches surfaces contaminated with it.

Children under two are most vulnerable to the virus alongside those with weakened immune systems such as the elderly and those with advanced cancer, according to medical experts.

There have also been worries that this could be like COVID-19, but experts have eased the fear as they are not similar because pandemics are typically caused by novel pathogens, which is not the case for HMPV.

Continue Reading

Health

Digitising Healthcare With Local Realities in Mind: Shaping The Future of Healthcare in Africa

Published

on

health financing fg

eHealth Africa (eHA) has urged governments and stakeholders to explore the critical factors beyond technology that are essential for the deployment of digital health solutions for the long-term success of public health systems across Africa. Data-backed interventions will help streamline operations and enable the formulation of interventions that appreciate the cultural norms when addressing the immediate needs of different communities within the region.

Speaking during a panel session at the Global Digital Health Forum 2024 in Nairobi, eHealth Africa’s Executive Director Atef Fawaz emphasised the importance of integrating technology with local cultures and addressing community-specific needs. “Understanding the unique healthcare challenges in each country allows us to deploy tech solutions that truly make an impact.”For instance, eHealth Africa successfully delivered over 5.8 million vaccines (5,801,209) to 351 primary healthcare facilities across states in Nigeria which was made possible through the deployment of the innovative Logistics Management Information System (LoMIS) application.

“The system significantly improved the availability of vaccines for Routine Immunisation (RI), ensuring timely and efficient distribution while eliminating stockouts at primary healthcare facilities. This intervention highlights our commitment to strengthening immunisation programs and enhancing healthcare delivery at the grassroots level,” he said.

In his contribution, Abdulhamid Yahaya, the Deputy Director of Global Health Informatics highlighted the need to understand the local cultural, social, and regulatory landscape to build solutions that are designed with local realities in mind.

eHealth Africa Board Member Micheline Ntiru said using technology provided stakeholders among them global health leaders, tech innovators, and development experts as well as local communities a platform to create the right solutions that work within the constraints of each community, and with the support of local leadership.

For instance, local health workers have been using mobile-based reminder systems to improve compliance and overall health outcomes while some local immunisation centres have been sending SMS reminders to parents as well as to provide educational messages about the diseases they protect against. Mobile phones, now available in nearly 80 per cent of African homes, can also be used during emergencies to dispatch mass announcements about satellite clinic locations and schedules.

According to the World Health Organisation, increased use of the Internet, email, social networking sites and availability of mobile phones facilitates the deployment of eHealth solutions, applications and services towards the improvement of national health systems. The use of technological eHealth solutions could also be used to encourage positive lifestyle changes to prevent and control common diseases.

The panel moderated by Ota Akhigbe, Director of Partnerships and Programs comprised of  Ms Ntiru (Delta40 ventures), Mr Yahaya (eHealth Africa), Chief Impact Officer at Tiko – Serah Malaba, Dr Olamide Okulaja (Maisha Meds), Audere Chief Executive Officer Dr Dino Rech, and  Rachel Alladian from Jacaranda. They discussed how strategic partnerships, regulatory compliance, and a deep understanding of local contexts are crucial for driving digital health innovations that can succeed in diverse regions.

The GDHF forum was attended by health scholars, researchers, and representatives from the Ministry of Health in Ethiopia, Tanzania, Kenya, Malaysia, Somalia and Sri Lanka as well as representatives from the World Bank, medicine manufacturers, technology vendors, UN agencies among others.

Continue Reading

Trending